Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.90p
   
  • Change Today:
    -0.15p
  • 52 Week High: 5.90
  • 52 Week Low: 1.09
  • Currency: UK Pounds
  • Shares Issued: 499.72m
  • Volume: 3,443,099
  • Market Cap: £14.49m
  • RiskGrade: 328
  • Beta: 0.14

Deal with Barclays    Trade now with Barclays Stockbrokers

Regulatory News

Warrant Extension, Debt Conversion & Equity Issue 01-Apr-2025 07:00 RNS
Extension of Warrants in Incanthera to 30 Sep 2025 01-Apr-2025 07:00 RNS
ImmuPharma proves unique Mechanism of Action-P140 13-Mar-2025 07:00 RNS
Holding(s) in Company 21-Feb-2025 11:36 RNS
£2.91m fundraising; related party transacti... 13-Feb-2025 07:00 RNS
Response to Share Price Movement 28-Jan-2025 12:57 RNS
Breakthrough Findings into Autoimmune Diseases 09-Jan-2025 07:00 RNS
Change of Auditor 23-Dec-2024 07:00 RNS
Holding(s) in Company 10-Dec-2024 14:36 RNS
Appointment of Company Secretary 04-Dec-2024 07:00 RNS
Extension of Warrants in Incanthera to 31 Mar 2025 09-Sep-2024 07:01 RNS
Half-year Report 09-Sep-2024 07:00 RNS
Holding(s) in Company 06-Aug-2024 13:41 RNS
Result of AGM 28-Jun-2024 12:17 RNS
Holding(s) in Company 06-Jun-2024 16:20 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 2.90p
Change Today -0.15p
% Change -4.92 %
52 Week High 5.90
52 Week Low 1.09
Volume 3,443,099
Shares Issued 499.72m
Market Cap £14.49m
Beta 0.14
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
72.8% below the market average72.8% below the market average72.8% below the market average72.8% below the market average72.8% below the market average
45.83% below the sector average45.83% below the sector average45.83% below the sector average45.83% below the sector average45.83% below the sector average
Price Trend
87.97% above the market average87.97% above the market average87.97% above the market average87.97% above the market average87.97% above the market average
87.76% above the sector average87.76% above the sector average87.76% above the sector average87.76% above the sector average87.76% above the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 01-Apr-2025

Time Volume / Share Price
16:11 247,253 @ 2.82p
16:27 81,670 @ 2.80p
16:12 2,500 @ 2.85p
15:59 160,304 @ 2.84p
15:57 12,577 @ 2.80p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page